学会発表
Interim report of a prospective, multicenter observational study of atezolizumab in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE
Yumi Fujimoto, Tatsunori Shimoi, Nobuhiro Shibata, Yukio Koibuchi, Naoki Hashimoto, Jun Yamamura, Takashi Morimoto, Michiko Tsuneizumi, Tetsuhiko Taira, Hiroshi Tada, Takashi Yamanaka, Mari S. Oba,
第60回日本癌治療学会学術集会 2022年10月
Fulvestrant with additional palbociclib in advanced or metastatic hormone receptor-positive HER2-negative breast cancer after progression to fulvestrant monotherapy: JBCRG- M07 (FUTURE trial)
Kenichi Watanabe, Naoki Niikura, Yuichiro Kikawa, Mari Oba, Kokoro Kobayashi, Hiroshi Tada, Shinji Ozaki, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Toshitaka Okuno, Nobutaka Iwakuma, Takeshi Takeshita, Takayuki Iwamoto, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Saji
2022.9 ESMO Poster WEB
Time-series cytokine profiles correlate with treatment responses and HRD in TNBC
Kosuke Kawaguchi, Don Pietro Saldajeno, Shinpei Kawaoka, Sunao Tanaka, Hiroko Bando, Tomomi Nishimura, Takayuki Kadoya, Takashi Yamanaka, Shigeru Imoto, Ravindranath M. Velaga, Yurina Maeshima, Masahiro Takada, Takayuki Ueno, Hiroshi Ishiguro, Seishi Ogawa, Hironori Haga, Shinji Ohno, Satoshi Morita, Norikazu Masuda, Masakazu Toi
2022年7月 第30回日本乳癌学会学術総会 厳選口演 ハイブリッド
HER2陽性乳癌での術前Dual-HER2 blockage 療法の長期予後検討(JBCRG-16試験)
Shoichiro Ohtani, Norikazu Masuda, Naohito Yamamoto, Hiroji Iwata, Hiroko Bando, Tomoyuki Aruga, Eriko Tokunaga, Tomomi Fujisawa, Toshimi Takano, Kennichi Inoue, Nobuyasu Suganuma, Masahiro Takada, Kenjiro Aogi, Kenichi Sakurai, Hideo Shigematsu, Katsumasa Kuroi, Hironori Haga, Shinji Ohno, Satoshi Morita, Masakazu Toi
2022年7月 第30回日本乳癌学会学術総会 厳選口演 ハイブリッド
日本国内における進行・再発乳癌患者レジストリ構築-Advanced Breast Cancer Database プロジェクト
Yasuaki Sagara, Naoki Niikura, Shigehira Saji, Shogo Nakamoto, Eriko Tokunaga, Yoshie Hasegawa, Nobuhiro Shibata, Hidetoshi Kawaguchi, Kokoro Kobayashi, Tsutomu Takashima, Masahiro Takada, Mitsuchika Hosoda, Minoru Miyashita, Hiraku Kumamaru, Norikazu Masuda
2022年7月 第30回日本乳癌学会学術総会 厳選口演 ハイブリッド
転移・再発乳癌における遺伝子パネル検査F1CDxとF1LCDxの治療方針決定に与える影響を検討する観察研究
Hiroshi Tada, Hiroko Masuda, Yayoi Adachi, Tsuguo Iwatani, Yasuaki Uemoto, Yoko Otani, Yukiko Kajiwara, Dai Kitagawa, Takahiro Kogawa, Yasuaki Sagara, Tadahiko Shien, Yuko Tanabe, Maki Tanioka, Masaya Hattori, Fumikata Hara, Hiroyuki Yasojima, Kenichi Yoshimura, Hiroji Iwata, Norikazu Masuda
2022年7月 第30回日本乳癌学会学術総会 ポスター ハイブリッド
Long-term follow-up of neoadjuvant dual anti-HER2 therapy with trastuzumab and lapatinib plus paclitaxel, with or without endocrine therapy for HER2‐positive primary breast cancer: Neo-LaTH (JBCRG-16) study.
Tomomi Fujisawa, Norikazu Masuda, Naohito Yamamoto, Hiroji Iwata, Hiroko Bando, Tomoyuki Aruga, Eriko Tokunaga, Shoichiro Ohtani, Toshimi Takano, Kenichi Inoue, Nobuyasu Suganuma, Masahiro Takada, Kenjiro Aogi, Kenichi Sakurai, Hideo Shigematsu, Katsumasa Kuroi, Hironori Haga, Shinji Ohno, Satoshi Morita, Masakazu Toi
2021.9 ESMO Poster WEB
Genomic profile and response prediction of eribulin mesylate based neoadjuvant chemotherapy in triple negative breast cancer patients
Tomomi Nishimura, Norikazu Masuda, Kosuke Kawaguchi, Masahiro Takada, Yurina Maeshima, Sunao Tanaka, Ravindranath M. Velaga, Yuichiro Kikawa, Takayuki Kadoya, Hiroko Bando, Rikiya Nakamura, Yutaka Yamamoto, Takayuki Ueno, Hiroyuki Yasojima, Hiroshi Ishiguro, Satoshi Morita, Shinji Ohno, Hironori Haga, Seishi Ogawa, Masakazu Toi
2021.9 ESMO Poster WEB
Immune microenvironment, homologous recombination deficiency and therapeutic response
Takayuki Ueno, Shigehisa Kitano, Norikazu Masuda, Daiki Ikarashi, Makiko Yamashita, Takayuki Kadoya, Hiroko Bando, Takashi Yamashita, Shoichiro Ohtani, Shigenori Nagai, Takahiro, Nakayama, Masato Takahashi, Shigehira Saji, Kenjiro Aogi, Ravindranath M. Velaga, Kosuke Kawaguchi, Satoshi Morita, Hironori Haga, Shinji Ohno, Masakazu Toi
2021.9 ESMO Poster WEB
Longitudinal alteration of cytokine profile in the peripheral blood and clinical response for neoadjuvant chemotherapy in triple-negative breast cancer patients (Translational Research of the JBCRG-22 Trial)
Kosuke Kawaguchi, Norikazu Masuda, Sunao Tanaka, Hiroko Bando, Tomomi Nishimura, Takayuki Kadoya, Takashi Yamanaka, Shigeru Imoto, Ravindranath M. Velaga, Nobuko Tamura, Tomoyuki Aruga, Yurina Maeshima, Masahiro Takada, Eiji Suzuki, Takayuki Ueno, Seishi Ogawa, Hironori Haga, Shinji Ohno, Satoshi Morita, Masakazu Toi
2021.9 ESMO Poster WEB